NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P26
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -24.74% |
| Q3 2025 | 13.01% |
| Q2 2025 | -3.30% |
| Q1 2025 | 2.70% |
| Q4 2024 | -199.80% |
| Q3 2024 | 76.84% |
| Q2 2024 | 1.14% |
| Q1 2024 | -65.09% |
| Q4 2023 | 6.36% |
| Q3 2023 | -20.53% |
| Q2 2023 | 8.03% |
| Q1 2023 | -209.17% |
| Q4 2022 | 12266.73% |
| Q3 2022 | -38.99% |
| Q2 2022 | 56.16% |
| Q1 2022 | -166.60% |
| Q4 2021 | 484.08% |
| Q3 2021 | 58.75% |
| Q2 2021 | -84.30% |
| Q1 2021 | 86.43% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |